Professor Dr. Lim Kheng Seang, a University of Malaya (Malaysia) graduate in 1999 with MRCP (UK), is a Professor of Neurology in the Faculty of Medicine, University of Malaya, and a Consultant Neurologist specializing in epilepsy at the University of Malaya Medical Centre and University Malaya Specialist Centre, Malaysia. He has been trained at the University of Malaya for his neurology subspecialty training (2008), followed by fellowship training in Melbourne (2011) and Cleveland (2017) for epilepsy. He completed his junior doctor training in Hospital Alor Setar, Kedah before joining University Malaya Medical Centre in 2005.

He is the President of the ASEAN Neurological Association (ASNA, 2023-2027), the General Secretary of the Asian and Oceanian Commission, International League Against Epilepsy (ILAE-AO), the chair of the Research Task Force in the commission, the past President of the Malaysian Society of Neurosciences (MSN) and Malaysian Epilepsy Society (PEM), an active member of the Malaysian Epilepsy Council and internationally and ex-chair of the Research Commission in the International Bureau of Epilepsy.

He has been involved in many trials of newer treatments (e.g., newer drugs and transcranial magnetic stimulation) in epilepsy. He also specializes in non-invasive and invasive epilepsy surgery assessment, including long-term video-EEG monitoring, intracranial monitoring with stereo-EEG, subdural and depth electrodes, electrocardiography, and cortical stimulation. Other areas of expertise included vagal nerve stimulation and callosotomy evaluation and monitoring.

He is currently the Associate Editor for Neurology Asia, an Editorial Board member of the Journal of Xiangya Medicine, and on the committee of the recent 7th Asian Oceanian Congress on Clinical Neurophysiology (AOCCN) held in February 2021. He has published ≥ 120 original papers with an H-index of 19, in journals including Neurology (IF:8.055), Epilepsia (IF:5.562), Neuron (14.403), and JAMA Neurology (IF:29.91). His research works focus on the psychosocial aspects of epilepsy, clinical studies especially epilepsy surgery and seizures in brain tumors, genetics in focal and familial epilepsies, pharmacogenomics and pharmacokinetics of antiepileptic drugs, quantitative EEG and quantitative MRI research, and artificial intelligence. He is active in research, being the principal investigator and co-investigator in many local and international research projects, and has a strong collaboration with Southeast Asia, Taiwan and Hong Kong, Australia and New Zealand, and the United Kingdom. He was recently awarded the Impact Oriented Interdisciplinary Research Grant (IIRG) Programme on epilepsy.